0001209191-23-058899.txt : 20231215 0001209191-23-058899.hdr.sgml : 20231215 20231215210012 ACCESSION NUMBER: 0001209191-23-058899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castagna Michael CENTRAL INDEX KEY: 0001674282 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 231492037 MAIL ADDRESS: STREET 1: 25134 RYE CANYON LOOP STREET 2: SUITE 300 CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-14 0 0000899460 MANNKIND CORP MNKD 0001674282 Castagna Michael 1 CASPER STREET DANBURY CT 06810 1 1 0 0 Chief Executive Officer 0 Common Stock, $.01 Par Value 2023-12-14 4 S 0 10000 4.00 D 2339147 D Common Stock, $.01 Par Value 2023-12-14 4 S 0 100000 4.00 D 2239147 D Common Stock, $.01 Par Value 2023-12-15 4 S 0 90482 4.00 D 2148665 D Transaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. All transactions contemplated by such plan have now been completed. Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023. Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023. All transactions contemplated by such plan have now been completed. /s/ Michael Castagna 2023-12-15